| |
| |
|
| Insider
Information: |
Robin Howard W |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
863,239 |
|
|
Indirect Shares
|
410 |
|
|
| Direct
Value |
$1,096,314 |
|
|
|
Indirect Value
|
$521 |
|
|
| Total
Shares |
863,649 |
|
|
| Total
Value |
$1,096,834 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -232.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nektar Therapeutics |
NKTR |
|
2024-05-17 |
863,239 |
2024-05-17 |
410 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2014-11-24 |
4 |
AS |
$15.02 |
$1,994,656 |
D/D |
(132,800) |
10,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2014-11-24 |
4 |
OE |
$14.52 |
$1,928,256 |
D/D |
132,800 |
142,800 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2014-11-28 |
4 |
OE |
$6.98 |
$983,789 |
D/D |
140,944 |
150,944 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2014-11-28 |
4 |
AS |
$17.02 |
$2,398,867 |
D/D |
(140,944) |
10,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2021-02-02 |
4 |
OE |
$8.80 |
$1,320,000 |
D/D |
150,000 |
608,693 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2021-02-02 |
4 |
AS |
$19.69 |
$2,966,025 |
D/D |
(150,000) |
458,693 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2021-02-03 |
4 |
OE |
$8.80 |
$1,320,000 |
D/D |
150,000 |
608,693 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2021-02-03 |
4 |
AS |
$19.72 |
$2,958,000 |
D/D |
(150,000) |
458,693 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2021-02-04 |
4 |
AS |
$20.10 |
$3,042,906 |
D/D |
(150,000) |
458,693 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2021-02-04 |
4 |
OE |
$8.80 |
$1,320,000 |
D/D |
150,000 |
608,693 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2014-12-01 |
4 |
OE |
$6.98 |
$1,459,211 |
D/D |
209,056 |
219,056 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2014-12-01 |
4 |
AS |
$17.00 |
$3,553,952 |
D/D |
(209,056) |
10,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
410,625 |
1,031,566 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2014-11-25 |
4 |
AS |
$15.31 |
$7,152,832 |
D/D |
(467,200) |
10,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
President & CEO |
• • – |
2014-11-25 |
4 |
OE |
$14.52 |
$6,783,744 |
D/D |
467,200 |
477,200 |
0 |
- |
|
140 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
